Peter Verhamme to Incidence
This is a "connection" page, showing publications Peter Verhamme has written about Incidence.
Connection Strength
0.065
-
A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study. Trials. 2020 Dec 09; 21(1):1005.
Score: 0.011
-
Diastolic left ventricular function in relation to circulating metabolic biomarkers in a population study. Eur J Prev Cardiol. 2019 01; 26(1):22-32.
Score: 0.010
-
The risk of nephrolithiasis is causally related to inactive matrix Gla protein, a marker of vitamin K status: a Mendelian randomization study in a Flemish population. Nephrol Dial Transplant. 2018 03 01; 33(3):514-522.
Score: 0.009
-
European guidelines on perioperative venous thromboembolism prophylaxis: Intensive care. Eur J Anaesthesiol. 2018 Feb; 35(2):142-146.
Score: 0.009
-
Age-adjusted D-dimer to rule out deep vein thrombosis: findings from the PALLADIO algorithm. J Thromb Haemost. 2018 02; 16(2):271-278.
Score: 0.009
-
Left ventricular function in relation to chronic residential air pollution in a general population. Eur J Prev Cardiol. 2017 09; 24(13):1416-1428.
Score: 0.009
-
Outcome-driven thresholds for ambulatory pulse pressure in 9938 participants recruited from 11 populations. Hypertension. 2014 Feb; 63(2):229-37.
Score: 0.007